The prognostic value of single and repeated ≥10% FEV1 declines for chronic lung allograft dysfunction

This publication has 9 references indexed in Scilit:

• Macrophage and CD8 T cell discordance are associated with acute lung allograft dysfunction progression
  The Journal of Heart and Lung Transplantation, 2024
• Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial
  The Lancet Respiratory Medicine, 2023
• Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspiration
  The Journal of Heart and Lung Transplantation, 2020
• The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart–lung transplantation Report—2019; Focus theme: Donor and recipient size match
  The Journal of Heart and Lung Transplantation, 2019
• Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLT
  The Journal of Heart and Lung Transplantation, 2019
• An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome
  European Respiratory Journal, 2014
• Restrictive allograft syndrome (RAS): A novel form of chronic lung allograft dysfunction
  The Journal of Heart and Lung Transplantation, 2011
• Prognostic Value of Bronchiolitis Obliterans Syndrome Stage 0-p in Single-Lung Transplant Recipients
  American Journal of Respiratory and Critical Care Medicine, 2005
• The Predictive Value of Bronchiolitis Obliterans Syndrome Stage 0-p
  American Journal of Respiratory and Critical Care Medicine, 2004